<p>Adage Capital Partners GP L.L.C. 在最近向證券交易委員會（SEC）提交的 13F 表格中披露，其在直覺外科公司（NASDAQ:ISRG - 免費報告）的股份在第二季度減少了 4.4%。該基金在季度內出售了 16,903 股後，持有 369,584 股該醫療設備提供商的股票。根據其最近向證券交易委員會（SEC）提交的文件，Adage Capital Partners GP L.L.C. 持有的直覺外科公司股份約佔 0.10%，價值為 200,836,000 美元。</p>
<p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
<ul>
<li>1.34 億美元的內部交易：這對 KMI、ISRG 和 QS 可能意味着什麼</li>
</ul>
<p>其他機構投資者也對該公司的股份進行了增減。先鋒集團（Vanguard Group Inc.）在第二季度將其在直覺外科公司的股份提高了 2.1%。先鋒集團目前持有 33,335,833 股該醫療設備提供商的股票，價值為 18,115,025,000 美元，此前在該期間內又購買了 670,302 股。道富銀行（State Street Corp）在第二季度將其在直覺外科公司的股份提高了 1.2%。道富銀行目前持有 15,552,203 股該醫療設備提供商的股票，價值為 8,451,223,000 美元，此前在上個季度又購買了 182,871 股。Geode Capital Management LLC 在第二季度將其在直覺外科公司的持股提高了 1.4%。Geode Capital Management LLC 目前持有 8,188,685 股該醫療設備提供商的股票，價值為 4,429,590,000 美元，此前又購買了 109,904 股。挪威銀行（Norges Bank）在第二季度獲得了直覺外科公司的新頭寸，價值為 2,569,260,000 美元。最後，景順（Invesco Ltd.）在第二季度將其在直覺外科公司的股份提高了 4.8%。景順目前持有 4,421,133 股該醫療設備提供商的股票，價值為 2,402,488,000 美元，此前又收購了 201,159 股。目前 83.64% 的股票由機構投資者持有。</p>
<h2>直覺外科的內部買賣</h2>
<p>在其他直覺外科的新聞中，執行副總裁 Brian Edward Miller 於 11 月 10 日星期一出售了 3,500 股直覺外科的股票。該股票以平均價格 575.00 美元出售，總交易額為 2,012,500.00 美元。交易完成後，該執行副總裁直接持有 5,758 股公司的股票，價值為 3,310,850 美元。此次交易使其持股減少了 37.81%。該交易已在證券交易委員會的法律文件中披露，可通過 SEC 網站獲取。此外，首席執行官 David J. Rosa 於 10 月 24 日星期五出售了 24,500 股該股票。該股票以平均價格 547.55 美元出售，總交易額為 13,414,975.00 美元。交易完成後，首席執行官持有 234,256 股公司的股票，價值約為 128,266,872.80 美元。這代表其持股減少了 9.47%。有關此次出售的更多細節可在官方 SEC 披露中找到。在上個季度，內部人士出售了 109,043 股公司股票，價值為 60,816,225 美元。目前 0.70% 的股票由內部人士持有。</p>
<h2>直覺外科股票表現</h2>
<ul>
<li>在特朗普關税政策下表現突出的前三隻股票</li>
</ul>
<p>NASDAQ ISRG 的股票在週五開盤價為 542.32 美元。該股票的市值為 1944.1 億美元，市盈率為 71.74，PEG 比率為 5.03，貝塔值為 1.68。直覺外科公司在過去 52 周的最低價為 425.00 美元，最高價為 616.00 美元。該公司的 50 日簡單移動平均線為 529.62 美元，200 日簡單移動平均線為 506.00 美元。</p>
<p>直覺外科（NASDAQ:ISRG - 獲取免費報告）最近於 10 月 21 日星期二發佈了季度財報。該醫療設備提供商報告本季度每股收益為 2.40 美元，超出市場共識預期的 1.99 美元，超出幅度為 0.41 美元。該公司在本季度的收入為 25.1 億美元，而市場共識預期為 24.1 億美元。直覺外科的股本回報率為 15.08%，淨利潤率為 28.58%。該公司的季度收入較去年同期增長了 22.9%。在去年同期，該公司每股收益為 1.84 美元。根據市場分析師的預測，直覺外科公司預計今年將發佈 6.43 美元的每股收益。</p>
<h2>分析師評級上調和下調</h2>
<ul>
<li>為什麼直覺外科對長期投資者來説是個明智的選擇</li>
</ul>
<p>幾家研究機構最近對 ISRG 進行了評估。加拿大皇家銀行（Royal Bank Of Canada）在 10 月 22 日的研究報告中將直覺外科的目標價設定為 625.00 美元，並給予該股票 “跑贏大盤” 的評級。高盛集團（Goldman Sachs Group）在 10 月 22 日的報告中將直覺外科的目標價從 567.00 美元上調至 621.00 美元，並給予該股票 “買入” 評級。Zacks Research 在 10 月 24 日的研究報告中將直覺外科的評級從 “持有” 上調至 “強烈買入”。Truist Financial 在 10 月 22 日的研究報告中將直覺外科的目標價設定為 620.00 美元，並給予該股票 “買入” 評級。最後，Raymond James Financial 在 10 月 22 日的研究報告中將直覺外科的目標價設定為 603.00 美元，並給予該公司 “跑贏大盤” 的評級。兩位投資分析師對該股票給予了 “強烈買入” 評級，十六位給予了 “買入” 評級，八位給予了 “持有” 評級，一位給予了 “賣出” 評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “適度買入”，共識目標價為 608.79 美元。</p>
<p><strong>查看我們對直覺外科的最新分析</strong></p>
<h2>關於直覺外科</h2>
<p>（免費報告）</p>
<p>直覺外科公司（Intuitive Surgical, Inc）開發、製造和銷售產品，使醫生和醫療服務提供者能夠提高美國及國際上微創護理的質量和可及性。該公司提供達芬奇手術系統（da Vinci Surgical System），該系統採用微創方法進行復雜手術；以及 Ion 內腔系統（Ion endoluminal system），其商業產品擴展到診斷程序，使微創肺活檢成為可能。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們認為比直覺外科更好的股票</li>
<li>現在可以購買的三隻巨頭成長股</li>
<li>Synopsys 因 Ansys 整合推動增長而出現看漲轉變</li>
<li>投資者必須瞭解的場外交易（OTC）股票</li>
<li>你能給自己最好的節日禮物是什麼？好市多股票</li>
<li>什麼是標準普爾 500 指數，它與其他指數有何不同</li>
<li>為什麼 Zscaler 股票在經歷 30% 的拋售後可能準備反彈</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在直覺外科嗎？</h2>
<p>在你考慮直覺外科之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而直覺外科並不在名單上。</p>
<p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

直覺外科

<p>Adage Capital Partners GP L.L.C. 在第二季度減少了對直覺外科（Intuitive Surgical, Inc.）的持股比例，下降了 4.4%，目前持有 369,584 股，價值 2 億零 840 萬美元。其他機構投資者如先鋒集團（Vanguard）、道富集團（State Street）和 Geode 也調整了他們的持倉。內部交易方面，執行副總裁 Brian Miller 和首席執行官 David Rosa 進行了大量出售。直覺外科報告了強勁的第三季度財報，收入增長了 22.9%。分析師們保持樂觀，加拿大皇家銀行（Royal Bank of Canada）設定了 625 美元的目標價</p>

<p>Adage Capital Partners GP L.L.C. trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 369,584 shares of the medical equipment provider's stock after selling 16,903 shares during the quarter. Adage Capital Partners GP L.L.C. owned approximately 0.10% of Intuitive Surgical worth $200,836,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>Adage Capital Partners GP L.L.C. 在最近向證券交易委員會（SEC）提交的 13F 表格中披露，其在直覺外科公司（NASDAQ:ISRG - 免費報告）的股份在第二季度減少了 4.4%。該基金在季度內出售了 16,903 股後，持有 369,584 股該醫療設備提供商的股票。根據其最近向證券交易委員會（SEC）提交的文件，Adage Capital Partners GP L.L.C. 持有的直覺外科公司股份約佔 0.10%，價值為 200,836,000 美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
</div><ul>
<li>$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS</li>
</ul>
<div class="lb-trans"><ul>
<li>1.34 億美元的內部交易：這對 KMI、ISRG 和 QS 可能意味着什麼</li>
</ul>
</div><p>Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider's stock worth $18,115,025,000 after purchasing an additional 670,302 shares during the period. State Street Corp raised its stake in Intuitive Surgical by 1.2% during the second quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider's stock worth $8,451,223,000 after buying an additional 182,871 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Intuitive Surgical by 1.4% in the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider's stock valued at $4,429,590,000 after buying an additional 109,904 shares during the period. Norges Bank acquired a new position in Intuitive Surgical in the second quarter valued at $2,569,260,000. Finally, Invesco Ltd. boosted its position in Intuitive Surgical by 4.8% during the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider's stock valued at $2,402,488,000 after acquiring an additional 201,159 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他機構投資者也對該公司的股份進行了增減。先鋒集團（Vanguard Group Inc.）在第二季度將其在直覺外科公司的股份提高了 2.1%。先鋒集團目前持有 33,335,833 股該醫療設備提供商的股票，價值為 18,115,025,000 美元，此前在該期間內又購買了 670,302 股。道富銀行（State Street Corp）在第二季度將其在直覺外科公司的股份提高了 1.2%。道富銀行目前持有 15,552,203 股該醫療設備提供商的股票，價值為 8,451,223,000 美元，此前在上個季度又購買了 182,871 股。Geode Capital Management LLC 在第二季度將其在直覺外科公司的持股提高了 1.4%。Geode Capital Management LLC 目前持有 8,188,685 股該醫療設備提供商的股票，價值為 4,429,590,000 美元，此前又購買了 109,904 股。挪威銀行（Norges Bank）在第二季度獲得了直覺外科公司的新頭寸，價值為 2,569,260,000 美元。最後，景順（Invesco Ltd.）在第二季度將其在直覺外科公司的股份提高了 4.8%。景順目前持有 4,421,133 股該醫療設備提供商的股票，價值為 2,402,488,000 美元，此前又收購了 201,159 股。目前 83.64% 的股票由機構投資者持有。</p>
</div><h2>Insider Buying and Selling at Intuitive Surgical</h2>
<div class="lb-trans"><h2>直覺外科的內部買賣</h2>
</div><p>In other Intuitive Surgical news, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the transaction, the executive vice president directly owned 5,758 shares of the company's stock, valued at $3,310,850. The trade was a 37.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares of the company's stock, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 109,043 shares of company stock worth $60,816,225. 0.70% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在其他直覺外科的新聞中，執行副總裁 Brian Edward Miller 於 11 月 10 日星期一出售了 3,500 股直覺外科的股票。該股票以平均價格 575.00 美元出售，總交易額為 2,012,500.00 美元。交易完成後，該執行副總裁直接持有 5,758 股公司的股票，價值為 3,310,850 美元。此次交易使其持股減少了 37.81%。該交易已在證券交易委員會的法律文件中披露，可通過 SEC 網站獲取。此外，首席執行官 David J. Rosa 於 10 月 24 日星期五出售了 24,500 股該股票。該股票以平均價格 547.55 美元出售，總交易額為 13,414,975.00 美元。交易完成後，首席執行官持有 234,256 股公司的股票，價值約為 128,266,872.80 美元。這代表其持股減少了 9.47%。有關此次出售的更多細節可在官方 SEC 披露中找到。在上個季度，內部人士出售了 109,043 股公司股票，價值為 60,816,225 美元。目前 0.70% 的股票由內部人士持有。</p>
</div><h2>Intuitive Surgical Stock Performance</h2>
<div class="lb-trans"><h2>直覺外科股票表現</h2>
</div><ul>
<li>Top 3 Stocks Powering Through Trump’s Tariff Policies</li>
</ul>
<div class="lb-trans"><ul>
<li>在特朗普關税政策下表現突出的前三隻股票</li>
</ul>
</div><p>Shares of NASDAQ ISRG opened at $542.32 on Friday. The stock has a market cap of $194.41 billion, a price-to-earnings ratio of 71.74, a PEG ratio of 5.03 and a beta of 1.68. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm's 50-day simple moving average is $529.62 and its 200 day simple moving average is $506.00.</p>
<div class="lb-trans"><p>NASDAQ ISRG 的股票在週五開盤價為 542.32 美元。該股票的市值為 1944.1 億美元，市盈率為 71.74，PEG 比率為 5.03，貝塔值為 1.68。直覺外科公司在過去 52 周的最低價為 425.00 美元，最高價為 616.00 美元。該公司的 50 日簡單移動平均線為 529.62 美元，200 日簡單移動平均線為 506.00 美元。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company's quarterly revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 earnings per share. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.</p>
<div class="lb-trans"><p>直覺外科（NASDAQ:ISRG - 獲取免費報告）最近於 10 月 21 日星期二發佈了季度財報。該醫療設備提供商報告本季度每股收益為 2.40 美元，超出市場共識預期的 1.99 美元，超出幅度為 0.41 美元。該公司在本季度的收入為 25.1 億美元，而市場共識預期為 24.1 億美元。直覺外科的股本回報率為 15.08%，淨利潤率為 28.58%。該公司的季度收入較去年同期增長了 22.9%。在去年同期，該公司每股收益為 1.84 美元。根據市場分析師的預測，直覺外科公司預計今年將發佈 6.43 美元的每股收益。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級上調和下調</h2>
</div><ul>
<li>Why Intuitive Surgical Is a No-Brainer for Long-Term Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼直覺外科對長期投資者來説是個明智的選擇</li>
</ul>
</div><p>Several research firms have recently weighed in on ISRG. Royal Bank Of Canada set a $625.00 price objective on Intuitive Surgical and gave the stock an &#34;outperform&#34; rating in a research report on Wednesday, October 22nd. The Goldman Sachs Group lifted their target price on Intuitive Surgical from $567.00 to $621.00 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, October 22nd. Zacks Research raised Intuitive Surgical from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Friday, October 24th. Truist Financial set a $620.00 price objective on shares of Intuitive Surgical and gave the stock a &#34;buy&#34; rating in a research report on Wednesday, October 22nd. Finally, Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the company an &#34;outperform&#34; rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $608.79.</p>
<div class="lb-trans"><p>幾家研究機構最近對 ISRG 進行了評估。加拿大皇家銀行（Royal Bank Of Canada）在 10 月 22 日的研究報告中將直覺外科的目標價設定為 625.00 美元，並給予該股票 “跑贏大盤” 的評級。高盛集團（Goldman Sachs Group）在 10 月 22 日的報告中將直覺外科的目標價從 567.00 美元上調至 621.00 美元，並給予該股票 “買入” 評級。Zacks Research 在 10 月 24 日的研究報告中將直覺外科的評級從 “持有” 上調至 “強烈買入”。Truist Financial 在 10 月 22 日的研究報告中將直覺外科的目標價設定為 620.00 美元，並給予該股票 “買入” 評級。最後，Raymond James Financial 在 10 月 22 日的研究報告中將直覺外科的目標價設定為 603.00 美元，並給予該公司 “跑贏大盤” 的評級。兩位投資分析師對該股票給予了 “強烈買入” 評級，十六位給予了 “買入” 評級，八位給予了 “持有” 評級，一位給予了 “賣出” 評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “適度買入”，共識目標價為 608.79 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我們對直覺外科的最新分析</strong></p>
</div><h2>About Intuitive Surgical</h2>
<div class="lb-trans"><h2>關於直覺外科</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.</p>
<div class="lb-trans"><p>直覺外科公司（Intuitive Surgical, Inc）開發、製造和銷售產品，使醫生和醫療服務提供者能夠提高美國及國際上微創護理的質量和可及性。該公司提供達芬奇手術系統（da Vinci Surgical System），該系統採用微創方法進行復雜手術；以及 Ion 內腔系統（Ion endoluminal system），其商業產品擴展到診斷程序，使微創肺活檢成為可能。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>3 Monster Growth Stocks to Buy Now</li>
<li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li>
<li>What Investors Must Know About Over-the-Counter (OTC) Stocks</li>
<li>The Best Holiday Present You Can Give Yourself? Costco Stock</li>
<li>What is the S&amp;P 500 and How It is Distinct from Other Indexes</li>
<li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比直覺外科更好的股票</li>
<li>現在可以購買的三隻巨頭成長股</li>
<li>Synopsys 因 Ansys 整合推動增長而出現看漲轉變</li>
<li>投資者必須瞭解的場外交易（OTC）股票</li>
<li>你能給自己最好的節日禮物是什麼？好市多股票</li>
<li>什麼是標準普爾 500 指數，它與其他指數有何不同</li>
<li>為什麼 Zscaler 股票在經歷 30% 的拋售後可能準備反彈</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在直覺外科嗎？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮直覺外科之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而直覺外科並不在名單上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Adage Capital Partners GP L.L.C. 在 Intuitive Surgical, Inc.持有價值 2.0084 億美元的股票